Publication November 12, 2026

Desmopressin: Authors' Reply Published in Neurourology and Urodynamics

On November 12, 2026, a new publication involving desmopressin appeared in Neurourology and Urodynamics. The item is titled "Authors' Reply to Letter to the Editor: Factors Affecting the Clinical Response to Desmopressin Treatment for Primary Monosymptomatic Nocturnal Enuresis in Children." This entry is an authors' reply responding to a prior letter to the editor regarding earlier research on desmopressin treatment in children with primary monosymptomatic nocturnal enuresis. The publication is indexed under PubMed ID 43017745. No findings, data, or conclusions from the reply are detailed here. Desmopressin remains an approved compound. Readers interested in the broader context of this ongoing scientific discussion can consult the compound overview for background information on desmopressin.

See the full desmopressin overview

Source: https://pubmed.ncbi.nlm.nih.gov/43017745/